With either Wegovy or Ozempic, your health provider will likely have you start with a low dosage of 0.25 milligrams (mg) of semaglutide per week, before increasing your dosage every 4 weeks until the desired effect is achieved
Alzheimers Dement (2015) 11(6):60821.e7
FDA warning against unapproved GLP-1 drugs for weight loss The official website of FDA clearly states that unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs can be risky for patients
[DOI] [PubMed] [Google Scholar] 184.Zhang R, Xiang Y, Ran Q, Deng X, Xiao Y, Xiang L, et al
Getting the Protocol Right: Dosage, Reconstitution, and Stacking Knowing where to inject is only part of the equation
Ozempic, while originally FDA-approved for managing type 2 diabetes, is now increasingly prescribed off-label for weight loss in patients without diabetes